Atreca Investors

19 investors on Angel Roster list Atreca in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Atreca can appear together.

Investors listed
19
With verified email
58%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 19 Atreca investors

The most complete profiles first. Showing 19 of 19.

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Daniel OmsteadVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Verified email available

  • Douglas CrawfordVerified

    Venture Capital · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Oleg NodelmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Sarah MarriottVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Scott PlatshonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Caroline Stout

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Jason Akus

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Priothera, Sutro Biopharma, Therachon, Caribou Biosciences and 26 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Robert Blazej

    Venture Capital · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

Frequently asked questions

How many Atreca investors are on Angel Roster?

Angel Roster lists 19 Atreca investors. 11 of them (58%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (18), Private Equity Firms (14) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Atreca investors invest in?

Among those that list a stage, the most common are Seed (1).

Where are Atreca investors based?

Most are based in the United States (19).

Which companies have Atreca investors backed?

The most-backed portfolio companies among them are Nuvation Bio (15), Syros Pharmaceuticals (14), Arcus Biosciences (12), Elevation Oncology (9) and GTx (9).

How do I contact Atreca investors?

Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.